CME Satellite Symposium

A CME Symposium during the 2026 San Diego Heart Failure Summer Symposium in San Diego, California.

AGENDA

3:55 PM           ATTR-CM: Epidemiology, Clinical Clues, and Diagnosis
                         Ronald Witteles, MD

4:10 PM            ATTR-CM Management: Focus on Disease-Modifying Therapies, HF Therapies, and Future Directions
                          Ahmad Masri, MD, MS

4:30 PM            Case Presentation: Optimization of ATTR-CM Management with Patient-Centered Care
                          Moderator: Marcus Anthony Urey, MD
                          Panelists: Ahmad Masri, MD, MS; Ronald Witteles, MD

4:50 PM            Question and Answer

EDUCATIONAL OBJECTIVES

■  Identify clinical clues that suggest the possibility for an ATTR-CM diagnosis.

■  Explain key steps in the diagnostic algorithm for ATTR-CM.

■  Describe the clinical evidence for ATTR-CM disease-modifying therapies, best adjustments of HF GDMT in patients with ATTR-CM, and novel therapies
in development.

Educational Grant

This activity is supported by an independent educational grant from Alnylam Pharmaceuticals, Inc. and BridgeBio.

CHAIR

Marcus Anthony Urey, MD
Associate Professor of Medicine
UC San Diego Health
San Diego, California

FACULTY

Ahmad Masri, MD, MS
Associate Professor of Medicine
Oregon Health & Science University
Portland, Oregon

Ronald Witteles, MD
Professor of Medicine (Cardiovascular Medicine)
Stanford University School of Medicine
Stanford, California